drugset
drugset / Trial / NCT05115513

Standardized Field Test for Marijuana Impairment II

NCT05115513 ↗

Phase 1 Completed 41 enrolled Yale University Hartford Hospital · collabNational Highway Traffic Safety Administration (NHTSA) · collabNational Institute on Drug Abuse (NIDA) · collab
Non-randomizedCrossoverSingle-blindOther

Summary

This research responds to NHTSA's request with a proposal to increase our understanding of smoked cannabis' (CNB's) acute effects on driving-relevant cognition and simulated driving performance, the persistence of these deficits over the hours after use, and the influence of prior experience with CNB on these effects. This extension study will aim to further investigate marijuana impaired behavior, using a similar design to our previous NHTSA Examine the Feasibility of a Standardized Field Test for Marijuana Impairment and the prior NIDA Neuroscience of Marijuana-Impaired Driving award, that used similar techniques and measures to quantify marijuana impaired automobile driving. We will be utilizing tasks and assessments that were shown to be strong indicators for cognitive and driving impairment in our NHTSA study.

Timeline

Start
2022-08-25
Primary completion
2023-08-21
Completion
2023-08-21

Drugs

EvaluationDrugModalityDoseRoute
Subject THC Unknown — Inhaled

Indications

No indication recorded.